JP2016516072A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516072A5
JP2016516072A5 JP2016503369A JP2016503369A JP2016516072A5 JP 2016516072 A5 JP2016516072 A5 JP 2016516072A5 JP 2016503369 A JP2016503369 A JP 2016503369A JP 2016503369 A JP2016503369 A JP 2016503369A JP 2016516072 A5 JP2016516072 A5 JP 2016516072A5
Authority
JP
Japan
Prior art keywords
contrast medium
formulation
enteric
intestinal
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016503369A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516072A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/030295 external-priority patent/WO2014145509A1/en
Publication of JP2016516072A publication Critical patent/JP2016516072A/ja
Publication of JP2016516072A5 publication Critical patent/JP2016516072A5/ja
Pending legal-status Critical Current

Links

JP2016503369A 2013-03-15 2014-03-17 低z原子による腸管ct造影材料 Pending JP2016516072A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361790734P 2013-03-15 2013-03-15
US201361798392P 2013-03-15 2013-03-15
US61/798,392 2013-03-15
US61/790,734 2013-03-15
PCT/US2014/030295 WO2014145509A1 (en) 2013-03-15 2014-03-17 Enteric ct contrast material based on low-z atoms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018038401A Division JP6843787B2 (ja) 2013-03-15 2018-03-05 低z原子による腸管ct造影材料

Publications (2)

Publication Number Publication Date
JP2016516072A JP2016516072A (ja) 2016-06-02
JP2016516072A5 true JP2016516072A5 (https=) 2017-04-20

Family

ID=51530440

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016503369A Pending JP2016516072A (ja) 2013-03-15 2014-03-17 低z原子による腸管ct造影材料
JP2018038401A Active JP6843787B2 (ja) 2013-03-15 2018-03-05 低z原子による腸管ct造影材料
JP2020144080A Pending JP2020193223A (ja) 2013-03-15 2020-08-28 低z原子による腸管ct造影材料

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018038401A Active JP6843787B2 (ja) 2013-03-15 2018-03-05 低z原子による腸管ct造影材料
JP2020144080A Pending JP2020193223A (ja) 2013-03-15 2020-08-28 低z原子による腸管ct造影材料

Country Status (6)

Country Link
US (1) US11033640B2 (https=)
EP (2) EP2968619B1 (https=)
JP (3) JP2016516072A (https=)
CN (2) CN105142680A (https=)
ES (1) ES2897624T3 (https=)
WO (1) WO2014145509A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2968619B1 (en) 2013-03-15 2021-08-11 The Regents of the University of California Enteric ct contrast material based on low-z atoms
JP2016528259A (ja) 2013-08-16 2016-09-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア シリコーン系腸管ct造影材料
WO2016172256A1 (en) 2015-04-20 2016-10-27 The Regents Of The University Of California Encapsulated gas or partial vacuum ct contrast material
US20200179539A1 (en) * 2016-06-22 2020-06-11 Board Of Regents, The University Of Texas System Contrast Agents and Methods of Making the Same for Spectral CT That Exhibit Cloaking and Auto-Segmentation
AU2017371069C1 (en) 2016-12-08 2025-02-27 Centre National De La Recherche Scientifique Bismuth-gadolinium nanoparticles
CN109100775B (zh) * 2018-07-06 2020-05-29 郑州云海信息技术有限公司 一种双层探测器的能量谱校正方法与装置
JP2020103571A (ja) * 2018-12-27 2020-07-09 キヤノンメディカルシステムズ株式会社 医用処理装置及びx線診断システム
US20220401587A1 (en) * 2021-05-05 2022-12-22 The Regents Of The University Of California Low x-ray attenuation change hard shelled oral contrast material
WO2024086131A1 (en) * 2022-10-18 2024-04-25 The Johns Hopkins University Systems and methods for angiography using multi-energy detectors

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592185A (en) * 1967-04-18 1971-07-13 Yeda Res & Dev Ferromagnetic contrast media and method of use
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
JPS6238172A (ja) 1985-08-12 1987-02-19 株式会社 高研 抗血栓性医用材料の製造方法
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
IL82834A (en) 1987-06-09 1990-11-05 Yissum Res Dev Co Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
GB9006671D0 (en) 1990-03-24 1990-05-23 Univ Manchester Diagnostic method and compositions
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
SE9101709L (sv) * 1991-06-03 1992-12-04 Karlshamns Lipidteknik Ab Lipidderivat som diagnostikum eller kontrastmedel
US5323780A (en) * 1992-08-07 1994-06-28 University Of Florida Research Foundation, Inc. Artifact-free imaging contrast agent
US5472682A (en) 1993-03-31 1995-12-05 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US5318769A (en) 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
FI963299A7 (fi) 1994-02-25 1996-08-23 Nycomed Imaging As Röntgenvarjoainekoostumukset, jotka sisältävät selluloosajohdannaisia
EP0756497A1 (en) 1994-04-21 1997-02-05 Nycomed Imaging As X-ray contrast compositions containing pharmaceutically acceptable clays
US5736121A (en) 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
US6818199B1 (en) * 1994-07-29 2004-11-16 James F. Hainfeld Media and methods for enhanced medical imaging
US5580579A (en) * 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
GB9603547D0 (en) 1996-02-20 1996-04-17 Nycomed Imaging As Contrast media
CN1221250C (zh) * 1998-04-09 2005-10-05 阿莫萨姆保健公司 微粒造影剂在研究生理参数的诊断成像中的应用
NO20052429D0 (no) * 2005-05-20 2005-05-20 Amersham Health As Konstrastmidler
GB0519391D0 (en) 2005-09-22 2005-11-02 Aion Diagnostics Ltd Imaging agents
US20070258907A1 (en) * 2006-04-24 2007-11-08 Davis Mark E Polymer-coated paramagnetic particles
EP2127682A1 (en) * 2008-05-28 2009-12-02 Deutsches Krebsforschungszentrum X-ray contrast agent based on bismuth oxide-nanoparticles
US20130266590A1 (en) 2010-12-13 2013-10-10 Novartis Ag Dimeric iap inhibitors
CA2819795A1 (en) 2010-12-15 2012-06-21 General Electric Company Nanoparticle composition and associated methods thereof
SG192181A1 (en) * 2011-01-28 2013-08-30 Univ Dalhousie Radiopaque embolic particles
US10071174B2 (en) 2011-06-06 2018-09-11 Portland State University Bismuth particle X-ray contrast agents
WO2013184061A1 (en) * 2012-06-04 2013-12-12 Migrata U.K. Limited Medical use of particles of titanium and/or titanium oxide
EP2968619B1 (en) 2013-03-15 2021-08-11 The Regents of the University of California Enteric ct contrast material based on low-z atoms
JP2016528259A (ja) * 2013-08-16 2016-09-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア シリコーン系腸管ct造影材料

Similar Documents

Publication Publication Date Title
JP2016516072A5 (https=)
Maisel et al. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse
Poinard et al. Polydopamine coating enhances mucopenetration and cell uptake of nanoparticles
Vrettos et al. Gastroretentive technologies in tandem with controlled-release strategies: A potent answer to oral drug bioavailability and patient compliance implications
Oshi et al. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease
Cho et al. In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications
Cu et al. Controlled surface modification with poly (ethylene) glycol enhances diffusion of PLGA nanoparticles in human cervical mucus
US9597419B2 (en) Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
JP2022003054A (ja) カプセル化された気体または部分真空のct造影材料
JP2015519330A5 (https=)
JP2018162284A5 (ja) 複数の被覆された粒子を含む組成物及び医薬製剤
US20080243113A1 (en) Modification of stent surfaces to impart functionality
JP2012012418A5 (https=)
JP6438406B2 (ja) 疎水性生理活性物質を送達するための組成物および方法
CN110408047B (zh) 纳米配位聚合物及其制备方法和应用
JP2014240439A5 (https=)
JP6846351B2 (ja) 粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤
Lee et al. Drug‐loaded mucoadhesive patch with active delivery and controlled releasing ability
Lim et al. Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors
JP2018090624A (ja) 低z原子による腸管ct造影材料
CN103120795B (zh) 一种靶向巨噬细胞的制剂
WO2015127389A1 (en) Hypotonic enema formulations and methods of use
JP2018516266A5 (https=)
Zhao et al. Acidified sucralfate encapsulated chitosan derivative nanoparticles as oral vaccine adjuvant delivery enhancing mucosal and systemic immunity
CN114796155A (zh) 天然活性物质-玉米蛋白纳米颗粒及其制备方法和用途